CAS No. |
174688-78-9 |
|---|---|
中文名称 |
(4R,7R,10R,13S,16R,19R,22S,25S,28S,31R,34R)-22-((1H-吲哚-3-基)甲基)-34-氨基-31-(4-氨基丁基)-13,25,28-三苄基-10,16-双((R)-1-羟基乙基)-7-(羟甲基)-19-(4-((异丙基氨基)甲基)苄基)-9,12,15,18,21,24,27,30,33-九氧代-1,2-二硫杂-5,8,11,14,17,20,23,26,29,32-十氮杂环五十三烷-4-羧酸 |
英文名称 |
(4R,7R,10R,13S,16R,19R,22S,25S,28S,31R,34R)-22-((1H-indol-3-yl)methyl)-34-amino-31-(4-aminobutyl)-13,25,28-tribenzyl-10,16-bis((R)-1-hydroxyethyl)-7-(hydroxymethyl)-19-(4-((isopropylamino)methyl)benzyl)-9,12,15,18,21,24,27,30,33-nonaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32-decaazacyclopentatriacontane-4-carboxylic acid |
别名 |
CYS-LYS-PHE-PHE-D-TRP-IAMP-THR-PHE-THR-SER-CYS;[DES-ALA1, DES-GLY2, DES-ASN5, D-TRP8, IAMP9]SOMATOSTATIN-14;CH-275;Cys-Lys-Phe-Phe-D-Trp-IAMp-Thr-Phe-Thr-Ser-Cys (Disulfide bridge Cys3-Cys14);L-Cysteine, L-cysteinyl-L-lysyl-L-phenylalanyl-L-phenylalanyl-D-tryptophyl-4-[[(1-methylethyl)amino]methyl]-L-phenylalanyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-, cyclic (1→11)-disulfide;CKFF-{d-Trp}-XTFTSC (Modifications: Cyclic Cys1-Cys11, X=4-[[(1-methylethyl)amino]methyl]-Phe) |
标准英文名 |
(4R,7R,10R,13S,16R,19R,22S,25S,28S,31R,34R)-22-((1H-indol-3-yl)methyl)-34-amino-31-(4-aminobutyl)-13,25,28-tribenzyl-10,16-bis((R)-1-hydroxyethyl)-7-(hydroxymethyl)-19-(4-((isopropylamino)methyl)benzyl)-9,12,15,18,21,24,27,30,33-nonaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32-decaazacyclopentatriacontane-4-carboxylic acid |
分子式 |
C74H98N14O14S2 |
分子量 |
1471.82 |
精确分子量 |
1470.68 |
SMILES |
CC(C)NCC1=CC=C(C[C@H]2NC(=O)[C@H](CC3=CNC4=CC=CC=C34)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)O)NC[C@H](CO)NC(=O)[C@@H]([C@@H](C)O)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@@H]([C@@H](C)O)NC2=O)C=C1 |
标准SMILES |
CC(C)NCC1=CC=C(C[C@H]2NC(=O)[C@H](CC3=CNC4=CC=CC=C34)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](N)CSSC[C@H](NC[C@H](CO)NC(=O)[C@H](NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](NC2=O)[C@@H](C)O)[C@@H](C)O)C(O)=O)C=C1 |
用途 |
CH275 is used in the research of Alzheimer's disease; it acts as a potent and selective somatostatin receptor 1 (sst1) agonist, activates neprilysin activity in vitro, and robustly increases neprilysin expression in the hippocampus in vivo, leading to a significant reduction in Aβ plaque load without causing toxic side effects. |
InChIKey |
LFOPEPKKBBIGHF-RXUBGYFDSA-N |
|
|
评论 |
|---|